CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Trend

CVS -- USA Stock  

USD 63.26  1.04  1.62%

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 130.6 B, Consolidated Income of 934 M or Cost of Revenue of 40 B, but also many exotic indicators such as Interest Coverage of 7.166, Long Term Debt to Equity of 0.8489 or Calculated Tax Rate of 94.8315. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Marginal Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization EBITDA of CVS Health Corporation with missing and latest data points interpolated. EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding [DepAmor] back to Earning Before Interest and Taxes EBIT.
View

14.83B

          10 Years Trend
Increasing
Stable
 Earnings Before Interest Taxes and Depreciation Amortization EBITDA 
      Timeline 

CVS Health Regression Statistics

Arithmetic Mean 1,736,847,500
Geometric Mean 166,156,018
Coefficient Of Variation 262.86
Mean Deviation 3,016,884,167
Median(72,200,000)
Standard Deviation 4,565,463,869
Range 14,913,030,000
R Value 0.25
R Squared 0.06
Significance 0.44
Slope 310,620,734

CVS Health Earnings Before Interest Taxes and Depreciation Amortization EBITDA Over Time

2009 (72,200,000) 
2018 (83,030,000) 
2019  14,830,000,000 

Other Fundumenentals of CVS Health

Search macroaxis.com